SETD7 and neoplasm: Furthermore, IHC analysis revealed a decreased proportion of Ki67-positive cells in SETD7-knockdown tumors and an elevated Ki67 index in SETD7-overexpressing tumors (Fig. 9I, J), confirming that SETD7 promotes tumor cell proliferation in vivo.